| YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy J Hu, D Qiu, A Yu, J Hu, H Deng, H Li, Z Yi, J Chen, X Zu Frontiers in oncology 11, 607224, 2021 | 83 | 2021 |
| N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target C Quan, O Belaydi, J Hu, H Li, A Yu, P Liu, Z Yi, D Qiu, W Ren, H Ma, ... Frontiers in Immunology 12, 697026, 2021 | 18 | 2021 |
| Radical prostatectomy after previous transurethral resection of the prostate: a systematic review and meta-analysis H Li, C Zhao, P Liu, J Hu, Z Yi, J Chen, X Zu Translational Andrology and Urology 8 (6), 712, 2019 | 17 | 2019 |
| Primary mucinous adenocarcinoma of the renal pelvis misdiagnosed as calculous pyonephrosis: a case report and literature review H Li, F Xie, C Zhao, Z Yi, J Chen, X Zu Translational andrology and urology 9 (2), 781, 2020 | 16 | 2020 |
| Emerging biomarkers for predicting bladder cancer lymph node metastasis C Zhang, J Hu, H Li, H Ma, B Othmane, W Ren, Z Yi, D Qiu, Z Ou, J Chen, ... Frontiers in oncology 11, 648968, 2021 | 14 | 2021 |
| Gut microbiota and tumor immune escape: A new perspective for improving tumor immunotherapy Y He, J Huang, Q Li, W Xia, C Zhang, Z Liu, J Xiao, Z Yi, H Deng, Z Xiao, ... Cancers 14 (21), 5317, 2022 | 13 | 2022 |
| Clinicopathologic features and survival outcomes for primary renal neuroendocrine neoplasms Z Yi, R Liu, J Hu, T He, Z Wang, Y Li, X Zu Clinical Genitourinary Cancer 19 (2), 155-161, 2021 | 12 | 2021 |
| Intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy: a pooled analysis Z Cai, H Li, J Hu, D Qiu, Z Yi, J Chen, X Zu Gland Surgery 10 (2), 706, 2021 | 6 | 2021 |
| Delayed versus standard ligature of the dorsal venous complex during laparoscopic radical prostatectomy: A systematic review and meta-analysis of comparative studies H Li, J Chen, Y Cui, P Liu, Z Yi, X Zu International Journal of Surgery 68, 117-125, 2019 | 6 | 2019 |
| Computer-aided diagnosis of prostate cancer based on deep neural networks from multi-parametric magnetic resonance imaging Z Yi, Z Ou, J Hu, D Qiu, C Quan, B Othmane, Y Wang, L Wu Frontiers in Physiology 13, 918381, 2022 | 5 | 2022 |
| Adjuvant chemotherapy in patients with locally advanced bladder cancer after neoadjuvant chemotherapy and radical cystectomy: a systematic review and pooled analysis Z Cai, H Jin, J Chen, J Hu, H Li, Z Yi, X Zu Translational Andrology and Urology 10 (1), 283, 2021 | 5 | 2021 |
| Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: a pooled analysis D Qiu, J Hu, T He, H Li, J Hu, Z Yi, J Chen, X Zu Translational Andrology and Urology 9 (5), 2094, 2020 | 5 | 2020 |
| Effects of Fibrin Clot Inhibitors and Statins on the Intravesical Bacille Calmette–Guérin Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis Z Cai, J Hu, B Othmane, H Li, D Qiu, Z Yi, J Chen, X Zu Frontiers in oncology 11, 614041, 2021 | 3 | 2021 |
| Recurrence factors in patients with Keratinizing squamous metaplasia of the bladder after surgical management: a single-center retrospective study Z Yi, Z Ou, X Guo, B Othmane, J Hu, W Ren, H Li, T He, D Qiu, Z Cai, ... Translational Andrology and Urology 10 (2), 734, 2021 | 3 | 2021 |
| HI-MViT: A lightweight model for explainable skin disease classification based on modified MobileViT Y Ding, Z Yi, M Li, J Long, S Lei, Y Guo, P Fan, C Zuo, Y Wang Digital Health 9, 20552076231207197, 2023 | 2 | 2023 |
| Efficacy of intra-arterial plus intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer: a pooled analysis C Cheng, D Qiu, J Chen, X Zu, J Liu, H Li, J Hu, Z Yi, T He, Z Chen, Y Cui Frontiers in Pharmacology 12, 707271, 2021 | 2 | 2021 |
| CTH-Net: A CNN and Transformer hybrid network for skin lesion segmentation Y Ding, Z Yi, J Xiao, M Hu, Y Guo, Z Liao, Y Wang Iscience 27 (4), 2024 | 1 | 2024 |
| FI‐Net: Rethinking Feature Interactions for Medical Image Segmentation Y Ding, J Liu, Y He, J Huang, H Liang, Z Yi, Y Wang Advanced Intelligent Systems, 2400201, 2024 | | 2024 |
| Rbbp8nl contributes to resistance to anticancer immunotherapy by creating a non-inflamed tumor microenvironment and attenuating CD8+ T cell infiltration Z Yi, J Liu, H Deng, H Jiao, X Zu bioRxiv, 2024.01. 21.575810, 2024 | | 2024 |
| Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology B Othmane, Z Yi, C Zhang, J Chen, X Zu, B Fan Frontiers in Public Health 10, 1036722, 2022 | | 2022 |
